GlassScriptPhysician profile
Neeti Gupta
NPI 1538226980
$3,615.50
in general payments reported to CMS, 2019-2025
19 companies · $1,052 in 2025
The $1,052 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $256 · 2021: $447 · 2022: $383 · 2023: $526 · 2024: $494 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,038 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,038.13 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,149.53 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $616.18 | 2019-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $214.95 | 2019-2025 | |
| Genentech USA, INC. | $202.71 | 2019-2025 | Xolair |
| Novartis Pharmaceuticals Corporation | $60.96 | 2019-2025 | |
| Optinose US, INC. | $56.83 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $45.33 | 2023-2025 | Dupixent |
| Amgen INC. | $34.00 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $31.48 | 2025 | Neffy |
| Galderma Laboratories, L.P. | $31.44 | 2025 | Nemluvio |
| Kaleo, INC. | $28.56 | 2019 | |
| Shire North American Group INC | $27.00 | 2019 | |
| Alk-Abello, INC | $26.37 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.82 | 2023 | Cuvitru |
| Biocryst US Sales Co., LLC | $16.95 | 2025 | Orladeyo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $16.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.08 | 2019 | |
| Pfizer INC. | $11.23 | 2019 | |
| Organon LLC | $10.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeti Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.